This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Attisano, L.
Right arrow Articles by Massague, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Attisano, L.
Right arrow Articles by Massague, J.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 03 1996, 1066-1073, Vol 16, No. 3
Copyright © 1996, American Society for Microbiology

Activation of signalling by the activin receptor complex

L Attisano, JL Wrana, E Montalvo and J Massague
Cell Biology and Genetics Program and Howard Hughes Medical Institute, New York 10021 USA.

Activin exerts its effects by simultaneously binding to two types of p rotein serine/threonine kinase receptors, each type existing in various isoforms. Using the ActR-IB and ActR-IIB receptor isoforms, we have investigated the mechanism of activin receptor activation. ActR-IIB are phosphoproteins with demonstrable affinity for each other. However, activin addition strongly promotes an interaction between these two proteins. Activin binds directly to ActR-IIB, and this complex associates with ActR-IB, which does not bind ligand on its own. In the resulting complex, ActR-IB becomes hyperphosphorylated, and this requires the kinase activity of ActR-IIB. Mutation of conserved serines and threonines in the GS domain, a region just upstream of the kinase domain in ActR-IB, abrogates both phosphorylation and signal propagation, suggesting that this domain contains phosphorylation sites required for signalling. ActR-IB activation can be mimicked by mutation of Thr-206 to aspartic acid, which yields a construct, ActR-IB(T206D), that signals in the absence of ligand. Furthermore, the signalling activity of this mutant construct is undisturbed by overexpression of a dominant negative kinase-defective ActR-IIB construct, indicating that ActR-IB(T206D) can signal independently of ActR-IIB. The evidence suggests that ActR-IIB acts as a primary activin receptor and ActR-IB acts as a downstream transducer of activin signals.


This article has been cited by other articles:

  • Huber, S., Stahl, F. R., Schrader, J., Luth, S., Presser, K., Carambia, A., Flavell, R. A., Werner, S., Blessing, M., Herkel, J., Schramm, C. (2009). Activin A Promotes the TGF-{beta}-Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells. J. Immunol. 182: 4633-4640 [Abstract] [Full Text]  
  • Bak, B., Carpio, L., Kipp, J. L, Lamba, P., Wang, Y., Ge, R.-S., Hardy, M. P, Mayo, K. E, Bernard, D. J (2009). Activins regulate 17{beta}-hydroxysteroid dehydrogenase type I transcription in murine gonadotrope cells. J Endocrinol 201: 89-104 [Abstract] [Full Text]  
  • Ciarmela, P., Wiater, E., Smith, S. M., Vale, W. (2009). Presence, Actions, and Regulation of Myostatin in Rat Uterus and Myometrial Cells. Endocrinology 150: 906-914 [Abstract] [Full Text]  
  • Blount, A. L., Vaughan, J. M., Vale, W. W., Bilezikjian, L. M. (2008). A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene. J. Biol. Chem. 283: 7016-7026 [Abstract] [Full Text]  
  • Korupolu, R. V., Muenster, U., Read, J. D., Vale, W., Fischer, W. H. (2008). Activin A/Bone Morphogenetic Protein (BMP) Chimeras Exhibit BMP-like Activity and Antagonize Activin and Myostatin. J. Biol. Chem. 283: 3782-3790 [Abstract] [Full Text]  
  • Refaat, B., Amer, S., Ola, B., Chapman, N., Ledger, W. (2008). The Expression of Activin- A- and - B-Subunits, Follistatin, and Activin Type II Receptors in Fallopian Tubes Bearing an Ectopic Pregnancy. J. Clin. Endocrinol. Metab. 93: 293-299 [Abstract] [Full Text]  
  • Hempel, N., How, T., Dong, M., Murphy, S. K., Fields, T. A., Blobe, G. C. (2007). Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion. Cancer Res. 67: 5231-5238 [Abstract] [Full Text]  
  • Liu, W., Wu, G., Li, W., Lobur, D., Wan, Y. (2007). Cdh1-Anaphase-Promoting Complex Targets Skp2 for Destruction in Transforming Growth Factor {beta}-Induced Growth Inhibition. Mol. Cell. Biol. 27: 2967-2979 [Abstract] [Full Text]  
  • Muller, M. R., Zheng, F., Werner, S., Alzheimer, C. (2006). Transgenic Mice Expressing Dominant-negative Activin Receptor IB in Forebrain Neurons Reveal Novel Functions of Activin at Glutamatergic Synapses. J. Biol. Chem. 281: 29076-29084 [Abstract] [Full Text]  
  • Okano, K., Schnaper, H. W., Bomsztyk, K., Hayashida, T. (2006). RACK1 Binds to Smad3 to Modulate Transforming Growth Factor-beta1-stimulated {alpha}2(I) Collagen Transcription in Renal Tubular Epithelial Cells. J. Biol. Chem. 281: 26196-26204 [Abstract] [Full Text]  
  • Mazerbourg, S., Hsueh, A. J.W. (2006). Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update 12: 373-383 [Abstract] [Full Text]  
  • Liu, Z H, Tsuchida, K, Matsuzaki, T, Bao, Y L, Kurisaki, A, Sugino, H (2006). Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.. J Endocrinol 189: 409-421 [Abstract] [Full Text]  
  • Lamba, P., Santos, M. M, Philips, D. P, Bernard, D. J (2006). Acute regulation of murine follicle-stimulating hormone {beta} subunit transcription by activin A. J Mol Endocrinol 36: 201-220 [Abstract] [Full Text]  
  • Muenster, U., Harrison, C. A., Donaldson, C., Vale, W., Fischer, W. H. (2005). An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties. J. Biol. Chem. 280: 36626-36632 [Abstract] [Full Text]  
  • Safwat, N., Ninomiya-Tsuji, J., Gore, A. J., Miller, W. L. (2005). Transforming Growth Factor {beta}-Activated Kinase 1 Is a Key Mediator of Ovine Follicle-Stimulating Hormone {beta}-Subunit Expression. Endocrinology 146: 4814-4824 [Abstract] [Full Text]  
  • Mazerbourg, S., Sangkuhl, K., Luo, C.-W., Sudo, S., Klein, C., Hsueh, A. J. W. (2005). Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses. J. Biol. Chem. 280: 32122-32132 [Abstract] [Full Text]  
  • Bamberger, C., Scharer, A., Antsiferova, M., Tychsen, B., Pankow, S., Muller, M., Rulicke, T., Paus, R., Werner, S. (2005). Activin Controls Skin Morphogenesis and Wound Repair Predominantly via Stromal Cells and in a Concentration-Dependent Manner via Keratinocytes. Am. J. Pathol. 167: 733-747 [Abstract] [Full Text]  
  • Alliston, T., Ko, T. C., Cao, Y., Liang, Y.-Y., Feng, X.-H., Chang, C., Derynck, R. (2005). Repression of Bone Morphogenetic Protein and Activin-inducible Transcription by Evi-1. J. Biol. Chem. 280: 24227-24237 [Abstract] [Full Text]  
  • Nudi, M., Ouimette, J.-F., Drouin, J. (2005). Bone Morphogenic Protein (Smad)-Mediated Repression of Proopiomelanocortin Transcription by Interference with Pitx/Tpit Activity. Mol. Endocrinol. 19: 1329-1342 [Abstract] [Full Text]  
  • Muttukrishna, S., Bearfield, C., Johns, J., Jauniaux, E. (2004). Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the villous tissue of miscarriage patients. Mol Hum Reprod 10: 793-798 [Abstract] [Full Text]  
  • Gunther, C. V., Riddle, D. L. (2004). Alternative Polyadenylation Results in a Truncated daf-4 BMP Receptor That Antagonizes DAF-7-mediated Development in Caenorhabditis elegans. J. Biol. Chem. 279: 39555-39564 [Abstract] [Full Text]  
  • Refaat, B A, Bahathiq, A O, Sockanathan, S, Stewart, R L, Wells, M, Ledger, W L (2004). Production and localization of activins and activin type IIA and IIB receptors by the human endosalpinx. Reproduction 128: 249-255 [Abstract] [Full Text]  
  • Harrison, C. A., Gray, P. C., Fischer, W. H., Donaldson, C., Choe, S., Vale, W. (2004). An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors. J. Biol. Chem. 279: 28036-28044 [Abstract] [Full Text]  
  • Zhou, Y., Scolavino, S., Funderburk, S. F., Ficociello, L. F., Zhang, X., Klibanski, A. (2004). Receptor Internalization-Independent Activation of Smad2 in Activin Signaling. Mol. Endocrinol. 18: 1818-1826 [Abstract] [Full Text]  
  • Lacerte, A., Lee, E.-H., Reynaud, R., Canaff, L., de Guise, C., Devost, D., Ali, S., Hendy, G. N., Lebrun, J.-J. (2004). Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin. Mol. Endocrinol. 18: 1558-1569 [Abstract] [Full Text]  
  • Poulaki, V., Mitsiades, N., Kruse, F. E., Radetzky, S., Iliaki, E., Kirchhof, B., Joussen, A. M. (2004). Activin A in the Regulation of Corneal Neovascularization and Vascular Endothelial Growth Factor Expression. Am. J. Pathol. 164: 1293-1302 [Abstract] [Full Text]  
  • Bernard, D. J. (2004). Both SMAD2 and SMAD3 Mediate Activin-Stimulated Expression of the Follicle-Stimulating Hormone {beta} Subunit in Mouse Gonadotrope Cells. Mol. Endocrinol. 18: 606-623 [Abstract] [Full Text]  
  • Chapman, S. C., Woodruff, T. K. (2003). Betaglycan Localization in the Female Rat Pituitary: Implications for the Regulation of Follicle-Stimulating Hormone by Inhibin. Endocrinology 144: 5640-5649 [Abstract] [Full Text]  
  • Wang, Y., Ge, W. (2003). Spatial Expression Patterns of Activin and Its Signaling System in the Zebrafish Ovarian Follicle: Evidence for Paracrine Action of Activin on the Oocytes. Biol. Reprod. 69: 1998-2006 [Abstract] [Full Text]  
  • Bernard, D. J., Burns, K. H., Haupt, B., Matzuk, M. M., Woodruff, T. K. (2003). Normal Reproductive Function in InhBP/p120-Deficient Mice. Mol. Cell. Biol. 23: 4882-4891 [Abstract] [Full Text]  
  • Harrison, C. A., Gray, P. C., Koerber, S. C., Fischer, W., Vale, W. (2003). Identification of a Functional Binding Site for Activin on the Type I Receptor ALK4. J. Biol. Chem. 278: 21129-21135 [Abstract] [Full Text]  
  • Dupont, J., McNeilly, J., Vaiman, A., Canepa, S., Combarnous, Y., Taragnat, C. (2003). Activin Signaling Pathways in Ovine Pituitary and L{beta}T2 Gonadotrope Cells. Biol. Reprod. 68: 1877-1887 [Abstract] [Full Text]  
  • Gray, P. C., Harrison, C. A., Vale, W. (2003). Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. USA 100: 5193-5198 [Abstract] [Full Text]  
  • Casagrandi, D., Bearfield, C., Geary, J., Redman, C.W., Muttukrishna, S. (2003). Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the placental tissue of patients with pre-eclampsia. Mol Hum Reprod 9: 199-203 [Abstract] [Full Text]  
  • Hempen, P. M., Zhang, L., Bansal, R. K., Iacobuzio-Donahue, C. A., Murphy, K. M., Maitra, A., Vogelstein, B., Whitehead, R. H., Markowitz, S. D., Willson, J. K. V., Yeo, C. J., Hruban, R. H., Kern, S. E. (2003). Evidence of Selection for Clones Having Genetic Inactivation of the Activin A Type II Receptor (ACVR2) Gene in Gastrointestinal Cancers. Cancer Res. 63: 994-999 [Abstract] [Full Text]  
  • Wiater, E., Vale, W. (2003). Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling. J. Biol. Chem. 278: 7934-7941 [Abstract] [Full Text]  
  • Chang, H., Brown, C. W., Matzuk, M. M. (2002). Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily. Endocr. Rev. 23: 787-823 [Abstract] [Full Text]  
  • Norwitz, E. R., Xu, S., Xu, J., Spiryda, L. B., Park, J. S., Jeong, K.-H., McGee, E. A., Kaiser, U. B. (2002). Direct Binding of AP-1 (Fos/Jun) Proteins to a SMAD Binding Element Facilitates Both Gonadotropin-releasing Hormone (GnRH)- and Activin-mediated Transcriptional Activation of the Mouse GnRH Receptor Gene. J. Biol. Chem. 277: 37469-37478 [Abstract] [Full Text]  
  • Yan, Y.-T., Liu, J.-J., Luo, Y., E, C., Haltiwanger, R. S., Abate-Shen, C., Shen, M. M. (2002). Dual Roles of Cripto as a Ligand and Coreceptor in the Nodal Signaling Pathway. Mol. Cell. Biol. 22: 4439-4449 [Abstract] [Full Text]  
  • Inman, G. J., Nicolas, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., Hill, C. S. (2002). SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-beta Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62: 65-74 [Abstract] [Full Text]  
  • Pangas, S. A., Rademaker, A. W., Fishman, D. A., Woodruff, T. K. (2002). Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary. J. Clin. Endocrinol. Metab. 87: 2644-2657 [Abstract] [Full Text]  
  • Matsuzaki, T., Hanai, S., Kishi, H., Liu, Z., Bao, Y., Kikuchi, A., Tsuchida, K., Sugino, H. (2002). Regulation of Endocytosis of Activin Type II Receptors by a Novel PDZ Protein through Ral/Ral-binding Protein 1-dependent Pathway. J. Biol. Chem. 277: 19008-19018 [Abstract] [Full Text]  
  • Norwitz, E. R., Xu, S., Jeong, K.-H., Bedecarrats, G. Y., Winebrenner, L. D., Chin, W. W., Kaiser, U. B. (2002). Activin A Augments GnRH-Mediated Transcriptional Activation of the Mouse GnRH Receptor Gene. Endocrinology 143: 985-997 [Abstract] [Full Text]  
  • Chen, Y.-G., Lui, H. M., Lin, S.-L., Lee, J. M., Ying, S.-Y. (2002). Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin. Exp. Biol. Med. 227: 75-87 [Abstract] [Full Text]  
  • Fragale, A., Puglisi, R., Morena, A. R., Stefanini, M., Boitani, C. (2001). Age-dependent activin receptor expression pinpoints activin A as a physiological regulator of rat Sertoli cell proliferation. Mol Hum Reprod 7: 1107-1114 [Abstract] [Full Text]  
  • Wildi, S, Kleeff, J, Maruyama, H, Maurer, C A, Buchler, M W, Korc, M (2001). Overexpression of activin A in stage IV colorectal cancer. Gut 49: 409-417 [Abstract] [Full Text]  
  • Visser, J. A., Olaso, R., Verhoef-Post, M., Kramer, P., Themmen, A. P. N., Ingraham, H. A. (2001). The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling. Mol. Endocrinol. 15: 936-945 [Abstract] [Full Text]  
  • Paquet, M.-E., Pece-Barbara, N., Vera, S., Cymerman, U., Karabegovic, A., Shovlin, C., Letarte, M. (2001). Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 10: 1347-1357 [Abstract] [Full Text]  
  • Chapman, S. C., Woodruff, T. K. (2001). Modulation of Activin Signal Transduction by Inhibin B and Inhibin-Binding Protein (InhBP). Mol. Endocrinol. 15: 668-679 [Abstract] [Full Text]  
  • Su, G. H., Bansal, R., Murphy, K. M., Montgomery, E., Yeo, C. J., Hruban, R. H., Kern, S. E. (2001). ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma. Proc. Natl. Acad. Sci. USA 98: 3254-3257 [Abstract] [Full Text]  
  • Quinn, Z. A., Yang, C.-C., Wrana, J. L., McDermott, J. C. (2001). Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res 29: 732-742 [Abstract] [Full Text]  
  • Miura, S., Takeshita, T., Asao, H., Kimura, Y., Murata, K., Sasaki, Y., Hanai, J.-I., Beppu, H., Tsukazaki, T., Wrana, J. L., Miyazono, K., Sugamura, K. (2000). Hgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA. Mol. Cell. Biol. 20: 9346-9355 [Abstract] [Full Text]  
  • Zhou, Y., Sun, H., Danila, D. C., Johnson, S. R., Sigai, D. P., Zhang, X., Klibanski, A. (2000). Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling. Mol. Endocrinol. 14: 2066-2075 [Abstract] [Full Text]  
  • Demeterco, C., Beattie, G. M., Dib, S. A., Lopez, A. D., Hayek, A. (2000). A Role for Activin A and Betacellulin in Human Fetal Pancreatic Cell Differentiation and Growth. J. Clin. Endocrinol. Metab. 85: 3892-3897 [Abstract] [Full Text]  
  • Kitamura, K., Aota, S.-i., Sakamoto, R., Yoshikawa, S.-I., Okazaki, K. (2000). Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation. Blood 95: 3371-3379 [Abstract] [Full Text]  
  • Abdalla, S. A., Pece-Barbara, N., Vera, S., Tapia, E., Paez, E., Bernabeu, C., Letarte, M. (2000). Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 9: 1227-1237 [Abstract] [Full Text]  
  • Chen, W., Woodruff, T. K., Mayo, K. E. (2000). Activin A-Induced HepG2 Liver Cell Apoptosis: Involvement of Activin Receptors and Smad Proteins. Endocrinology 141: 1263-1272 [Abstract] [Full Text]  
  • Shoji, H., Tsuchida, K., Kishi, H., Yamakawa, N., Matsuzaki, T., Liu, Z., Nakamura, T., Sugino, H. (2000). Identification and Characterization of a PDZ Protein That Interacts with Activin Type II Receptors. J. Biol. Chem. 275: 5485-5492 [Abstract] [Full Text]  
  • Gray, P. C., Greenwald, J., Blount, A. L., Kunitake, K. S., Donaldson, C. J., Choe, S., Vale, W. (2000). Identification of a Binding Site on the Type II Activin Receptor for Activin and Inhibin. J. Biol. Chem. 275: 3206-3212 [Abstract] [Full Text]  
  • Gunther, C., Georgi, L., Riddle, D. (2000). A Caenorhabditis elegans type I TGF beta receptor can function in the absence of type II kinase to promote larval development. Development 127: 3337-3347 [Abstract]  
  • Nagarajan, R. P., Zhang, J., Li, W., Chen, Y. (1999). Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4. J. Biol. Chem. 274: 33412-33418 [Abstract] [Full Text]  
  • Chen, Y.-G., Massague, J. (1999). Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-beta Family Receptors. J. Biol. Chem. 274: 3672-3677 [Abstract] [Full Text]  
  • Barbara, N. P., Wrana, J. L., Letarte, M. (1999). Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-beta Superfamily. J. Biol. Chem. 274: 584-594 [Abstract] [Full Text]  
  • Lebrun, J.-J., Takabe, K., Chen, Y., Vale, W. (1999). Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling. Mol. Endocrinol. 13: 15-23 [Abstract] [Full Text]  
  • Brummel, T., Abdollah, S., Haerry, T. E., Shimell, M. J., Merriam, J., Raftery, L., Wrana, J. L., O'Connor, M. B. (1999). The Drosophila Activin receptor Baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development. Genes Dev. 13: 98-111 [Abstract] [Full Text]  
  • Macias-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M., Wrana, J. L. (1998). Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2. J. Biol. Chem. 273: 25628-25636 [Abstract] [Full Text]  
  • Takeda, K., Ichijo, H., Fujii, M., Mochida, Y., Saitoh, M., Nishitoh, H., Sampath, T. K., Miyazono, K. (1998). Identification of a Novel Bone Morphogenetic Protein-responsive Gene That May Function as a Noncoding RNA. J. Biol. Chem. 273: 17079-17085 [Abstract] [Full Text]  
  • Zhou, S., Buckhaults, P., Zawel, L., Bunz, F., Riggins, G., Le Dai, J., Kern, S. E., Kinzler, K. W., Vogelstein, B. (1998). Targeted deletion of Smad4 shows it is required for transforming growth factor beta  and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 95: 2412-2416 [Abstract] [Full Text]  
  • Hata, A., Lagna, G., Massagué, J., Hemmati-Brivanlou, A. (1998). Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12: 186-197 [Abstract] [Full Text]  
  • Chen, Y., Bhushan, A., Vale, W. (1997). Smad8 mediates the signaling of the receptor serine kinase. Proc. Natl. Acad. Sci. USA 94: 12938-12943 [Abstract] [Full Text]  
  • Abdollah, S., Macias-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L., Wrana, J. L. (1997). Tbeta RI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling. J. Biol. Chem. 272: 27678-27685 [Abstract] [Full Text]  
  • Heikinheimo, K., Begue-Kirn, C., Ritvos, O., Tuuri, T., Ruch, J.V. (1997). The Activin-binding Protein Follistatin is Expressed in Developing Murine Molar and Induces Odontoblast-like Cell Differentiation in vitro. JDR 76: 1625-1636 [Abstract]  
  • Toyono, T., Nakashima, M., Kuhara, S., Akamine, A. (1997). Expression of TGF-{beta} Superfamily Receptors in Dental Pulp. JDR 76: 1555-1560 [Abstract]  
  • Namiki, M., Akiyama, S., Katagiri, T., Suzuki, A., Ueno, N., Yamaji, N., Rosen, V., Wozney, J. M., Suda, T. (1997). A Kinase Domain-truncated Type I Receptor Blocks Bone Morphogenetic Protein-2-induced Signal Transduction in C2C12 Myoblasts. J. Biol. Chem. 272: 22046-22052 [Abstract] [Full Text]  
  • Persson, U., Souchelnytskyi, S., Franzen, P., Miyazono, K., ten Dijke, P., Heldin, C.-H. (1997). Transforming Growth Factor (TGF-beta )-specific Signaling by Chimeric TGF-beta Type II Receptor with Intracellular Domain of Activin Type IIB Receptor. J. Biol. Chem. 272: 21187-21194 [Abstract] [Full Text]  
  • Oh, S P, Li, E (1997). The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse.. Genes Dev. 11: 1812-1826 [Abstract]  
  • Martens, J. W. M., de Winter, J. P., Timmerman, M. A., McLuskey, A., van Schaik, R. H. N., Themmen, A. P. N., de Jong, F. H. (1997). Inhibin Interferes with Activin Signaling at the Level of the Activin Receptor Complex in Chinese Hamster Ovary Cells. Endocrinology 138: 2928-2936 [Abstract] [Full Text]  
  • Ethier, J.-F., Lussier, J. G., Silversides, D. W. (1997). Bovine Activin Receptor Type IIB Messenger Ribonucleic Acid Displays Alternative Splicing Involving a Sequence Homologous to Src-Homology 3 domain Binding Sites. Endocrinology 138: 2425-2434 [Abstract] [Full Text]  
  • Kretzschmar, M, Liu, F, Hata, A, Doody, J, Massague, J (1997). The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.. Genes Dev. 11: 984-995 [Abstract]  
  • Nakao, A., Roijer, E., Imamura, T., Souchelnytskyi, S., Stenman, G., Heldin, C.-H., ten Dijke, P. (1997). Identification of Smad2, a Human Mad-related Protein in the Transforming Growth Factor beta Signaling Pathway. J. Biol. Chem. 272: 2896-2900 [Abstract] [Full Text]  
  • Armes, N., Smith, J. (1997). The ALK-2 and ALK-4 activin receptors transduce distinct mesoderm-inducing signals during early Xenopus development but do not co-operate to establish thresholds. Development 124: 3797-3804 [Abstract]  
  • Chang, C, Wilson, P., Mathews, L., Hemmati-Brivanlou, A (1997). A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis. Development 124: 827-837 [Abstract]  
  • Chen, Y., Lebrun, J.-J., Vale, W. (1996). Regulation of transforming growth factor beta - and activin-induced transcription by mammalian Mad proteins. Proc. Natl. Acad. Sci. USA 93: 12992-12997 [Abstract] [Full Text]  
  • Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., Miyazono, K. (1996). Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5. J. Biol. Chem. 271: 21345-21352 [Abstract] [Full Text]  
  • Renucci, A, Lemarchandel, V, Rosa, F (1996). An activated form of type I serine/threonine kinase receptor TARAM-A reveals a specific signalling pathway involved in fish head organiser formation. Development 122: 3735-3743 [Abstract]  
  • Qing, J., Zhang, Y., Derynck, R. (2000). Structural and Functional Characterization of the Transforming Growth Factor-beta -induced Smad3/c-Jun Transcriptional Cooperativity. J. Biol. Chem. 275: 38802-38812 [Abstract] [Full Text]  
  • Esparza-Lopez, J., Montiel, J. L., Vilchis-Landeros, M. M., Okadome, T., Miyazono, K., Lopez-Casillas, F. (2001). Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-beta Superfamily. SPECIALIZED BINDING REGIONS FOR TRANSFORMING GROWTH FACTOR-beta AND INHIBIN A. J. Biol. Chem. 276: 14588-14596 [Abstract] [Full Text]  
  • Cocolakis, E., Lemay, S., Ali, S., Lebrun, J.-J. (2001). The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin. J. Biol. Chem. 276: 18430-18436 [Abstract] [Full Text]  
  • Parks, W. T., Frank, D. B., Huff, C., Renfrew Haft, C., Martin, J., Meng, X., de Caestecker, M. P., McNally, J. G., Reddi, A., Taylor, S. I., Roberts, A. B., Wang, T., Lechleider, R. J. (2001). Sorting Nexin 6, a Novel SNX, Interacts with the Transforming Growth Factor-beta Family of Receptor Serine-Threonine Kinases. J. Biol. Chem. 276: 19332-19339 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»